Decoy Therapeutics, Inc. (DCOY)
0.81
+0.06
(+7.93%)
USD |
NASDAQ |
Jan 23, 10:33
Decoy Therapeutics Cash from Investing (Quarterly): -0.20M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Eli Lilly & Co. | -2.983B |
| Amgen, Inc. | -414.00M |
| CorMedix, Inc. | -291.32M |
| Vor Biopharma, Inc. | -0.244M |
| Humacyte, Inc. | -0.049M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -1.647M |
| Cash from Financing (Quarterly) | 5.862M |
| Free Cash Flow | -4.433M |
| Free Cash Flow Per Share (Quarterly) | -3.419 |
| Free Cash Flow to Equity (Quarterly) | -1.647M |
| Free Cash Flow to Firm (Quarterly) | -1.647M |
| Free Cash Flow Yield | -918.6% |